Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut de Recherches Internationales Servier
With
ADIR, a Servier Group company
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged between 18 and 85 years (both inclusive)
Acute ischemic stroke that occured between 72 hours (3 days) and 192 hours (8 days) (both inclusive) before inclusion
You may not be if
Any non-selection criteria, which could have occurred after the selection visit
Positive urinary or blood pregnancy test (for female patients of child bearing potential)
Any clinically significant findings from the local laboratory test likely to interfere with the ability to participate in the study and / or with the study outcome
Severe renal impairment detected in the local laboratory test
Severe hepatic impairment or liver enzymes abnormalities found in the local laboratory test
Stroke due to cerebral venous thrombosis
Brain MRI showing a severe microangiopathy
Brain imaging showing an acute haemorrhagic stroke or a symptomatic haemorrhagic transformation of the brain infarct
Qualifying ischemic cerebral event older than 192 hours at inclusion
Any clinically relevant abnormalities detected during the examinations likely to interfere with study procedures or study outcome,
Repeated prolongation of ECG QTcF
Patient or authorised representative refusing to attend study visits or to take part in the study
Clareo Health | Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event
